Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

1997 • 862 citations

Epidemiology of Nosocomial Fungal Infections, with Emphasis on Candida Species

1995 • 651 citations

A Randomized and Blinded Multicenter Trial of High‐Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects

2003 • 499 citations

Resistance Mechanisms in Clinical Isolates of Candida albicans

2002 • 459 citations

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

2001 • 451 citations

Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998

2000 • 384 citations

Has Antifungal Susceptibility Testing Come of Age?

2002 • 357 citations

Antifungal susceptibility testing

1993 • 351 citations

A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

2001 • 334 citations

International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program

1998 • 284 citations

International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents

1999 • 270 citations

In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp

2002 • 239 citations

Comparison of Visual and Spectrophotometric Methods of Broth Microdilution MIC End Point Determination and Evaluation of a Sterol Quantitation Method for In Vitro Susceptibility Testing of Fluconazole and Itraconazole against Trailing and Nontrailing Candida Isolates

2002 • 161 citations

Epidemiology of opportunistic invasive mycoses.

2002 • 159 citations

In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant Isolates

2003 • 155 citations

The Trailing End Point Phenotype in Antifungal Susceptibility Testing Is pH Dependent

1999 • 146 citations

In Vitro Activities of Posaconazole (Sch 56592) Compared with Those of Itraconazole and Fluconazole against 3,685 Clinical Isolates of Candida spp. and Cryptococcus neoformans

2001 • 143 citations

Interpretation of Trailing Endpoints in Antifungal Susceptibility Testing by the National Committee for Clinical Laboratory Standards Method

1998 • 137 citations

Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine

1995 • 130 citations

Novel triazole antifungal agents

2000 • 130 citations

In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection

1997 • 128 citations

Antifungal Susceptibility Testing: Technical Advances and Potential Clinical Applications

1997 • 127 citations

In Vitro Activities of 5-Fluorocytosine against 8,803 Clinical Isolates of Candida spp.: Global Assessment of Primary Resistance Using National Committee for Clinical Laboratory Standards Susceptibility Testing Methods

2002 • 125 citations

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location

2003 • 87 citations

Standardization of antifungal susceptibility testing and clinical relevance.

1998 • 84 citations

ANTIFUNGAL SUSCEPTIBILITY TESTING

2001 • 69 citations

Glucan synthase inhibitors as antifungal agents

2001 • 66 citations

Evolution of Antifungal Susceptibility amongCandidaSpecies Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis

2001 • 62 citations

Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazole

1996 • 49 citations

Antifungal Activity of Voriconazole (UK-109,496), Fluconazole and Amphotericin B Against HematogenousCandida kruseiInfection in Neutropenic Guinea Pig Model

1999 • 41 citations

In Vitro Antifungal Susceptibility Testing

2001 • 37 citations

Change in Colony Morphology of Candida lusitaniae in Association with Development of Amphotericin B Resistance

2002 • 37 citations

Present status of the detection of antifungal resistance: the perspective from both sides of the ocean

2001 • 35 citations

Susceptibility Testing of Fungi and Correlation with Clinical Outcome

1997 • 33 citations

Role of Newer Azoles in Surgical Patients

1999 • 31 citations

Resistance to antifungal agents in the critical care setting: problems and perspectives.

1996 • 29 citations

Evaluation of a Method for Identification of Candida dubliniensis Bloodstream Isolates

2003 • 25 citations

Is Antifungal Susceptibility Testing Useful in Guiding Fluconazole Therapy?

1996 • 22 citations

Effects of pentamidine alone and in combination with ketoconazole or itraconazole on the growth of Candida albicans

1990 • 21 citations

Impact of endpoint definition on the outcome of antifungal susceptibility tests with Candida species: 24- versus 48-h incubation and 50 versus 80% reduction in growth

2001 • 18 citations

Carolinas Medical Center

2004 • 12 citations

Impact of endpoint definition on the outcome of antifungal susceptibility tests with Candida species: 24- versus 48-h incubation and 50 versus 80% reduction in growth

2001 • 10 citations

High Concentration of Ampicillin and the Eagle Effect among Gram-Negative Rods

1981 • 8 citations

Cited By (0)

Loading...